1 completed, 1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Prostate Specific Antigens: new trials by email Literature Review of Prostate Specific Antigens trials Research Report on Prostate Specific Antigens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy Prostate Specific Antigens, Positive Digital Rectal Examination | Terminated | National Cancer Institute (NCI) | 3 | 2024-03-20 | 2025-07-10 | |
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer T-cell receptor alternate reading frame protein (TARP) peptide vaccine, T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine - Prostate Specific Antigens, Prostate Neoplasms | Phase 1 | Completed | National Cancer Institute (NCI) | 41 | 2009-05-11 | 2022-10-12 |
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Protein Subunit Vaccines (1) · TARP (1)
National Cancer Institute (NCI) (2)
United States (2)
Hoyoung M Maeng, M.D. (1) · Ismail B Turkbey, M.D. (1)